UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002976
Receipt number R000003611
Scientific Title Effects of 5-FU and heparin-based portal infusion chemotherapy combined with MMC and CDDP after curative resection of pancreatic cancer.
Date of disclosure of the study information 2010/01/20
Last modified on 2017/10/15 22:32:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of 5-FU and heparin-based portal infusion chemotherapy combined with MMC and CDDP after curative resection of pancreatic cancer.

Acronym

5-FU and heparin-based portal infusion chemotherapy after the resection of pancreatic cancer

Scientific Title

Effects of 5-FU and heparin-based portal infusion chemotherapy combined with MMC and CDDP after curative resection of pancreatic cancer.

Scientific Title:Acronym

5-FU and heparin-based portal infusion chemotherapy after the resection of pancreatic cancer

Region

Japan


Condition

Condition

patients after the resection of pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of 5-FU and heparin-based portal infusion chemotherapy as the adjuvant therapy of pancreatic cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

overall survival

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

with the portal infusion chemotherapy after the resection of pancreatic cancer

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Cases with the curative resection of pancreatic cancer

Key exclusion criteria

inoperable cases

Target sample size

48


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Minoru Kitago

Organization

Department of Surgery, Keio University School of Medicine

Division name

Department of Surgery

Zip code


Address

Shinanomachi 35, Shinnjuku-ku, Tokyo 160-8582

TEL

03-3353-1211(ext62529)

Email

contact@keio-hpbts.jp


Public contact

Name of contact person

1st name
Middle name
Last name Minoru Kitago

Organization

Department of Surgery, Keio University School of Medicine

Division name

Department of Surgery

Zip code


Address

Shinanomachi 35, Shinnjuku-ku, Tokyo 160-8582

TEL

03-3353-1211(ext62529)

Homepage URL


Email

contact@keio-hpbts.jp


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

non

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院


Other administrative information

Date of disclosure of the study information

2010 Year 01 Month 20 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2001 Year 07 Month 05 Day

Date of IRB


Anticipated trial start date

2001 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 01 Month 05 Day

Last modified on

2017 Year 10 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003611


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name